News

Robin Lawrence welcomes Claire

Claire Darke joins the Liberal Democrats

Last year Park Ward resident Claire Darke was so angered by the Labour Council's decision to close Compton Pool and by the inaction of Labour councillors that she launched a massive "Save Compton Pool Campaign" and as a result, stood as an independent candidate in the local elections in May. She had realised that the Liberal Democrats were successfully campaigning to make improvements locally in many different ways and after the election was over she decided to join them.

12 Jun 2007
View

Campbell calls on Brown to set target date for Iraq troop withdrawal

Giving evidence to the Iraq Commission, Menzies Campbell yesterday called on Gordon Brown to give a target date for withdrawal of British troops from Iraq when he becomes Prime Minister. He said that during his visit to Iraq Gordon Brown should make clear to the Iraqi government that our continuing presence in the country is unsustainable.

12 Jun 2007
View

Drug offers hope for Parkinson's

The progression of Parkinson's disease could be slowed or even stopped by a drug commonly used to treat high blood pressure, a study in Nature suggests. Tests on mice at Northwestern University in Chicago showed isradipine can rejuvenate the brain neurons which are dying in Parkinson's patients. The disease, which mainly affects those aged over 40, leads to tremors and ultimately the inability to walk.

12 Jun 2007
View

Stem cell first for Parkinson's

US researchers have for the first time injected human stem cells into monkeys with Parkinson's symptoms, seen as a key step in the fight to find a cure. The stem cells, which have been injected into rodents in the past, initially stopped the monkeys' damaged brain cells from deteriorating. The primates' condition did however start to slide after four months, the study in the PNAS journal said. Stem cells offer great hope for cures, but a breakthrough remains elusive.

12 Jun 2007
View

NHS to review arthritis drugs use

The NHS treatment watchdog has agreed to review its guidance on the use of three drugs for rheumatoid arthritis. The National Institute for Health and Clinical Excellence (NICE) will look again at Humira, Enbrel and Remicade. Last year it ruled if a patient did not respond to one of the drugs - from a class known as anti-TNF medicines - they should not get another. But various charities, manufacturers and the Royal College of Nursing (RCN) appealed against that decision. The drugs will now undergo a further review of their NHS use.

12 Jun 2007
View

This website uses cookies

Like most websites, this site uses cookies. Some are required to make it work, while others are used for statistical or marketing purposes. If you choose not to allow cookies some features may not be available, such as content from other websites. Please read our Cookie Policy for more information.

Essential cookies enable basic functions and are necessary for the website to function properly.
Statistics cookies collect information anonymously. This information helps us to understand how our visitors use our website.
Marketing cookies are used by third parties or publishers to display personalized advertisements. They do this by tracking visitors across websites.